Australia Is Latest Country to Say ‘No’ to Leqembi
Eisai and Biogen’s Alzheimer’s drug Leqembi (generic name lecanemab) was the first fully-FDA approved disease-modifying treatment for early-stage Alzheimer’s disease in United States history,…
Eisai and Biogen’s Alzheimer’s drug Leqembi (generic name lecanemab) was the first fully-FDA approved disease-modifying treatment for early-stage Alzheimer’s disease in United States history,…
Can a seemingly harmless virus in the gut wreak havoc on the brain decades after the initial infection? And could catching and treating an…
Roughly a quarter of all Americans over the age of 40 in the U.S. take statin drugs — which lower levels of cholesterol —…
In 1907, a Belgian chemist named Leo Baekelend developed a revolutionary new material that would soon become a hallmark of the modern era: fully…
In the brains of people with Alzheimer’s diseases, problematic proteins called beta-amyloid build up and clump together in plaques, harming and eventually killing off…
After months of delays, Alzheon gears up to present data from their pivotal Phase 3 drug trial, while Athira Pharma pays out a settlement…
A Trump executive order has banned DEI initiatives across the federal government. Scientists say the move could undermine trial diversity and derail the quest…
When Eisai announced in a press release this week that they’d secured FDA approval for an Alzheimer’s drug dosage change, it seemed like a…
In 2023, U.S. Surgeon General Dr. Vivek Murthy sounded the alarm about the social isolation and loneliness epidemic. A recent poll found that three…
With the 2024 FDA approval of Eli Lilly’s Kisunla for early-stage Alzheimer’s disease, there are now two fairly similar anti-amyloid on the market in…
Two days after President Donald Trump took office, sweeping bans — mostly temporary — went into effect across the U.S. National Institutes of Health…
Would you still participate in an Alzheimer’s clinical trial if you found out that because of your genetics, you were more vulnerable to serious…
Alzheimer’s disease is a lot more than memory loss. Many people with the disease develop psychiatric problems like agitation — which are hard to…
In the 1950s, doctors Carlton Gajdusek and Vincent Zigas trekked over mountains and across rivers to study a mysterious and fatal neurological disease called…
In 2022, more Canadians died by medical euthanasia than from pneumonia, Alzheimer’s, or liver disease. The Quebec government announced in October that people with…